IFP Advisors’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.39K Sell
453
-238
-34% -$5.26K ﹤0.01% 3438
2026
Q1
$16.1K Buy
691
+212
+44% +$6.61K ﹤0.01% 2896
2025
Q4
$21.2K Buy
479
+400
+506% +$22.5K ﹤0.01% 2696
2025
Q3
$5.78K Sell
79
-1,391
-95% -$90.7K ﹤0.01% 3167
2025
Q2
$90.2K Buy
1,470
+118
+9% +$6.58K ﹤0.01% 1692
2025
Q1
$78.5K Buy
1,352
+24
+2% +$1.51K ﹤0.01% 1663
2024
Q4
$70.9K Buy
1,328
+1,029
+344% +$50.4K ﹤0.01% 1651
2024
Q3
$13K Buy
299
+288
+2,618% +$9.61K ﹤0.01% 2320
2024
Q2
$308 Buy
+11
New +$290 ﹤0.01% 3121
2023
Q4
Sell
-92
Closed -$1.95K 3111
2023
Q3
$1.95K Sell
92
-8
-8% -$218 ﹤0.01% 2846
2023
Q2
$3.4K Buy
100
+84
+525% +$2.8K ﹤0.01% 2675
2023
Q1
$848 Hold
16
﹤0.01% 3111
2022
Q4
$1K Sell
16
-34
-68% -$1.04K ﹤0.01% 4324
2022
Q3
$5K Hold
50
﹤0.01% 4014
2022
Q2
$5K Hold
50
﹤0.01% 3765
2022
Q1
$5K Buy
50
+40
+400% +$2.01K ﹤0.01% 3765
2021
Q4
$1K Sell
10
-100
-91% -$6.51K ﹤0.01% 2978
2021
Q3
$9K Buy
+110
New +$8.04K ﹤0.01% 2314

Other funds holding DOCS

IFP Advisors's DOCS Position: Q2 2026 in Review

IFP Advisors reduced its Doximity (DOCS) stake by 34% in Q2 2026, selling an estimated $5.26K and leaving 453 shares worth $9.39K. The position accounts for ﹤0.01% of the portfolio, ranked #3438.

IFP Advisors first reported a position in DOCS in Q3 2021 and has held it in 18 quarters since. The position peaked at $90.2K in Q2 2025. 358 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • IFP Advisors held 453 shares of Doximity worth $9.39K as of Q2 2026.
  • IFP Advisors sold 238 Doximity shares in Q2 2026, an estimated $5.26K.
  • Doximity made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3438 holding.
  • IFP Advisors first reported a position in Doximity in Q3 2021 and has held it in 18 quarters since.
  • IFP Advisors's Doximity position peaked at $90.2K in Q2 2025.
  • 358 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.